We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
+1.84%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
10 Year Est. Return
AUM
$206M
AUM Growth
-$5.39M
Cap. Flow
-$5.98M
Cap. Flow %
-2.91%
Top 10 Hldgs %
51.68%
Holding
35
New
3
Increased
2
Reduced
26
Closed
2

Top Buys

1
MTH icon
Meritage Homes
MTH
+$5.95M
2
DOW icon
Dow Inc
DOW
+$1.99M
3
CTVA icon
Corteva
CTVA
+$1.01M
4
GLD icon
SPDR Gold Trust
GLD
+$33.6K
5
PFE icon
Pfizer
PFE
+$4.17K

Sector Composition

1 Technology 24.83%
2 Healthcare 23.02%
3 Consumer Discretionary 13.02%
4 Industrials 9.17%
5 Financials 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.98T
$16.8M 8.19%
125,743
-733
-0.6% -$93.1K
AAPL icon
2
Apple
AAPL
$4.89T
$12.5M 6.05%
251,656
-916
-0.4% -$44.6K
AZO icon
3
AutoZone
AZO
$50B
$11.6M 5.64%
10,556
-14
-0.1% -$14.7K
GLD icon
4
SPDR Gold Trust
GLD
$130B
$11.1M 5.37%
82,960
+272
+0.3% +$33.6K
BFH icon
5
Bread Financial
BFH
$3.97B
$9.62M 4.68%
85,985
-319
-0.4% -$38.6K
MCK icon
6
McKesson
MCK
$98.5B
$9.33M 4.54%
69,428
-172
-0.2% -$21.4K
RUSHA icon
7
Rush Enterprises Class A
RUSHA
$6.19B
$9.13M 4.44%
562,273
CCJ icon
8
Cameco
CCJ
$38B
$9.07M 4.41%
844,896
-2,643
-0.3% -$28.5K
GILD icon
9
Gilead Sciences
GILD
$169B
$8.96M 4.35%
132,551
-388
-0.3% -$25.5K
MCHP icon
10
Microchip Technology
MCHP
$44.4B
$8.25M 4.01%
190,218
-778
-0.4% -$34.6K
FHI icon
11
Federated Hermes
FHI
$4.53B
$8.03M 3.91%
247,158
-511
-0.2% -$16.1K
AMLP icon
12
Alerian MLP ETF
AMLP
$12.7B
$7.69M 3.74%
156,233
-518
-0.3% -$25.6K
AVGO icon
13
Broadcom
AVGO
$1.78T
$7.67M 3.73%
266,610
-860
-0.3% -$25.1K
UNH icon
14
UnitedHealth
UNH
$384B
$7.29M 3.55%
29,884
-20,590
-41% -$4.95M
CELG
15
DELISTED
Celgene Corp
CELG
$6.53M 3.17%
70,621
-210
-0.3% -$19.9K
DAL icon
16
Delta Air Lines
DAL
$57B
$6.49M 3.15%
114,330
-240
-0.2% -$13.4K
MTH icon
17
Meritage Homes
MTH
$5.17B
$6.04M 2.94%
+235,408
New +$5.95M
AYI icon
18
Acuity Brands
AYI
$10.2B
$5.92M 2.88%
42,960
-141
-0.3% -$19.4K
CTSH icon
19
Cognizant
CTSH
$21.1B
$5.84M 2.84%
92,163
-297
-0.3% -$19.5K
CE icon
20
Celanese
CE
$5.02B
$5.31M 2.58%
49,278
-49,483
-50% -$5.13M
JAZZ icon
21
Jazz Pharmaceuticals
JAZZ
$15.2B
$5.16M 2.51%
36,203
-121
-0.3% -$16.3K
CI icon
22
Cigna
CI
$75.1B
$4.81M 2.34%
30,522
-78
-0.3% -$12.2K
BIIB icon
23
Biogen
BIIB
$30.8B
$4.16M 2.02%
17,780
-63
-0.4% -$14.5K
WAB icon
24
Wabtec
WAB
$44.8B
$3.77M 1.83%
52,521
-174
-0.3% -$12.3K
DD icon
25
DuPont de Nemours
DD
$18.1B
$2.83M 1.37%
29,993
-14,734
-33% -$1.76M

Similar funds

Muhlenkamp & Co's Q2 2019 Portfolio in Review

As of Q2 2019, Muhlenkamp & Co held 35 positions worth $206M, down 2.6% from $211M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Muhlenkamp & Co's Q2 2019 filing shows 3 new, 2 increased, 26 reduced and 2 closed positions. Its largest new stake was Meritage Homes: 235,408 shares worth $6.04M. The largest sale was Celanese, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Muhlenkamp & Co's largest Q2 2019 buy was Meritage Homes: 235,408 shares worth $6.04M.
  • Muhlenkamp & Co added most to SPDR Gold Trust in Q2 2019, an estimated $33.6K increase.
  • Muhlenkamp & Co's biggest Q2 2019 reduction was Celanese, cutting an estimated $5.13M.
  • Muhlenkamp & Co fully exited GameStop in Q2 2019, selling an estimated $2.37M.
  • Muhlenkamp & Co's ten largest holdings make up 52% of its $206M portfolio in Q2 2019.
  • Muhlenkamp & Co opened 3 new positions and closed 2 in Q2 2019.
  • Muhlenkamp & Co's portfolio value fell 2.6% quarter-over-quarter to $206M.

Based on Muhlenkamp & Co's 13F filing for Q2 2019, filed 28 Aug 2019.